Literature DB >> 2015007

Production of IgM rheumatoid factor by normal lymphocytes after stimulation with preparations containing IgM rheumatoid factor from patients with juvenile arthritis.

G Nesher1, T L Moore, T G Osborn, R W Dorner.   

Abstract

Preparations containing IgM rheumatoid factor (RF) and hidden IgM RF were isolated from the serum samples of nine patients with juvenile rheumatoid arthritis. Six of these preparations stimulated lymphocytes from normal donors to produce IgG and IgM, of which up to 11% had IgM RF activity. In contrast, the polyclonal activator pokeweed mitogen also stimulated IgM production, but only 1% had IgM RF activity. A relation between the activator and IgM RF or hidden IgM RF is suggested. This is based on the positive correlation between IgM RF concentration in these preparations and their ability to stimulate lymphocytes to produce IgG, IgM, and IgM RF. These data indicate that preparations from patients with juvenile rheumatoid arthritis containing IgM RF and hidden IgM RF are potent stimulants of lymphocytes from normal donors, with specific production of IgM RF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015007      PMCID: PMC1004362          DOI: 10.1136/ard.50.3.142

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

1.  Dunlop-Dottridge lecture. Rehumatoid arthritis, rheumatoid factor and the Epstein-Barr virus.

Authors:  J H Vaughan
Journal:  J Rheumatol       Date:  1979 Jul-Aug       Impact factor: 4.666

2.  Monocyte-mediated suppression of rheumatoid factor production in normal subjects.

Authors:  M Okawa-Takatsuji; S Aotsuka; S Uwatoko; R Yokohari; K Inagaki
Journal:  Clin Immunol Immunopathol       Date:  1988-02

3.  Hidden 19S IgM rheumatoid factor in juvenile rheumatoid arthritis.

Authors:  T L Moore; R W Dorner; T D Weiss; A R Baldassare; J Zuckner
Journal:  Pediatr Res       Date:  1980-10       Impact factor: 3.756

4.  Induction of human rheumatoid factor producing cells by aggregated IgG.

Authors:  E J Pisko; R A Turner; S L Foster
Journal:  Arthritis Rheum       Date:  1982-09

5.  In vitro synthesis of immunoglobulins and IgM-rheumatoid factor by blood mononuclear cells of patients with rheumatoid arthritis.

Authors:  N Olsen; M Ziff; H E Jasin
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

6.  Polyclonal activation of murine B lymphocytes by immune complexes.

Authors:  E L Morgan; W O Weigle
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

7.  Enhanced in vitro synthesis of IgM rheumatoid factor in rheumatoid arthritis.

Authors:  W J Koopman; R E Schrohenloher
Journal:  Arthritis Rheum       Date:  1980-09

8.  The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes.

Authors:  M Lorber; D Samuel; P Amlot; G S Panayi
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

9.  Enhancement of in vitro immunoglobulin synthesis of rheumatoid lymphocytes by aggregated human gamma globulin.

Authors:  K Yamasaki; M Ziff
Journal:  Arthritis Rheum       Date:  1977-03

10.  In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects.

Authors:  L Slaughter; D A Carson; F C Jensen; T L Holbrook; J H Vaughan
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.